What percentage of individuals who experience a major depressive episode will have a recurrent episode?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recurrence Risk After a First Major Depressive Episode

Approximately 50% of individuals who experience a first major depressive episode will have a recurrent episode. 1

Progressive Risk with Multiple Episodes

The recurrence risk follows a clear escalating pattern with each subsequent episode:

  • After one episode: ~50% recurrence risk 1
  • After two episodes: ~70% recurrence risk 1
  • After three episodes: ~90% recurrence risk 1

This progressive increase in recurrence probability is well-established across multiple guideline sources, with the risk increasing by approximately 16% with each successive episode 2.

Clinical Implications for Treatment Duration

These recurrence statistics directly inform treatment recommendations:

  • First episode: Continue antidepressant treatment for 4-12 months after remission 1
  • Recurrent depression (≥2 episodes): Prolonged or potentially lifelong treatment may be beneficial 1

The rationale is straightforward: antidepressant medication does not prevent relapse if discontinued at the end of the acute phase, but systematic reviews demonstrate that continued treatment after remission protects against recurrence and relapse 1.

Important Caveats

Approximately 50% of individuals with a first episode recover and never have another episode 3, while about 15% experience unremitting depression without a year free of episodes even after 23 years of follow-up 3. This bimodal distribution highlights that major depression follows two distinct life course trajectories, though predicting which trajectory an individual will follow at first onset remains challenging 4.

The median episode duration is approximately 12 weeks 3, and the risk of recurrence progressively decreases as the duration of recovery increases 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Multiple recurrences of major depressive disorder.

The American journal of psychiatry, 2000

Research

Major Depression and Its Recurrences: Life Course Matters.

Annual review of clinical psychology, 2022

Related Questions

What are the appropriate dosing, contraindications, precautions, and monitoring recommendations for Remeron (mirtazapine) in treating major depressive disorder?
What is the appropriate management for a 44-year-old patient with major depressive disorder, generalized anxiety disorder, and attention‑deficit/hyperactivity disorder who is experiencing acute anxiety and insomnia related to the upcoming birthday of a relative who died two years ago?
What is the appropriate next treatment for an 18‑year‑old with severe major depressive disorder and prominent grief who has not responded to adequate trials of bupropion (Wellbutrin), escitalopram (Lexapro), fluoxetine (Prozac), and sertraline (Zoloft)?
What management advice should be given for a patient with chronic major depressive disorder and generalized anxiety disorder who has been taking 60 mg daily of an antidepressant?
What are the next steps for a 16-year-old female (YOF) with self-harm, Dissociative Identity Disorder (DID), Major Depressive Disorder (MDD), and Generalized Anxiety Disorder (GAD) who has shown an inadequate response to fluoxetine (Prozac) 20mg?
What is the recommended management of recurrent pleural effusion?
Can phentermine be used safely in a patient with bigeminal premature atrial contractions?
How should I manage a patient taking cariprazine (Vraylar) 3 mg daily, sertraline (Zoloft) 150 mg daily, aripiprazole (Abilify) 10 mg daily, trazodone 150 mg at bedtime, and clonazepam (Klonopin) 0.5 mg twice daily who continues to have social anxiety?
What are the risk factors for dextrocardia with situs inversus?
What are alternative therapies to cholestyramine for managing hypercholesterolemia?
Which cognitive screening tool—Mini‑Mental State Examination (MMSE) or Brief Interview for Mental Status (BIMS)—is appropriate for diagnosing Alzheimer’s disease in an older adult?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.